U.S., Sept. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07164937) titled 'Imaging and Gait Analysis in FSHD Patients' on Nov. 21, 2024.
Brief Summary: Facioscapulohumeral muscular dystrophy (FSHD) is a common genetic muscle disorder characterized by progressive and often asymmetric muscle weakness, with high variability in clinical severity and disease progression. This study aims to integrate advanced imaging and motion analysis technologies to comprehensively evaluate the impact of FSHD on muscle degeneration and motor functionality.
The primary objective is to characterize the distribution and severity of muscle degeneration using magnetic resonance imaging (MRI) and correlate these findings with mot...